Showing results (1601-1610 of 2,693) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|July 24, 2018
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
The Lancet. Infectious Diseases|August 7, 2018
Global burden of recurrent vulvovaginal candidiasis: a systematic reviewDavid W Denning, Matthew Kneale, Jack D Sobel, et al.
The Lancet. Infectious Diseases|September 26, 2016
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013Louisa Degenhardt, Fiona Charlson, Jeff Stanaway, et al.
The Lancet. Infectious Diseases|April 30, 2017
Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trialLuis Rivera, Rasmus S Pedersen, Lourdes Peña, et al.
The Lancet. Infectious Diseases|May 24, 2017
Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trialPunnee Pitisuttithum, Kobporn Boonnak, Supat Chamnanchanunt, et al.
The Lancet. Infectious Diseases|May 23, 2017
Symptomatic dengue infection during pregnancy and livebirth outcomes in Brazil, 2007-13: a retrospective observational cohort studyLaura B Nascimento, Cláudio M Siqueira, Giovanini E Coelho, et al.
The Lancet. Infectious Diseases|May 10, 2017
Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trialMichelle J Groome, Anthonet Koen, Alan Fix, et al.
The Lancet. Infectious Diseases|May 10, 2017
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysisRadha Rajasingham, Rachel M Smith, Benjamin J Park, et al.
The Lancet. Infectious Diseases|September 18, 2016
Requirements for global elimination of hepatitis B: a modelling studyShevanthi Nayagam, Mark Thursz, Elisa Sicuri, et al.
The Lancet. Infectious Diseases|September 18, 2016
In-host adaptation and acquired triazole resistance in Aspergillus fumigatus: a dilemma for clinical managementPaul E Verweij, Jianhua Zhang, Alfons J M Debets, et al.
Pageof 270